Physician profile
Dodd A Sims
NPI 1124006788
$1,173.60
in general payments reported to CMS, 2019-2025
21 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $89.40 · 2021: $355 · 2022: $62.15 · 2023: $145 · 2024: $115 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $355.83 | 2019-2025 | Ubrelvy, Qulipta |
| Novo Nordisk INC | $177.56 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $153.69 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $107.79 | 2021-2025 | |
| Amarin Pharma, INC. | $51.71 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $49.75 | 2019-2020 | |
| Exact Sciences Corporation | $27.54 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $24.57 | 2025 | Arexvy, Shingrix |
| Amgen INC. | $23.37 | 2025 | Repatha |
| Abbott Laboratories | $21.41 | 2023 | Freestyle Libre 3 |
| Esperion Therapeutics, INC. | $20.85 | 2021 | |
| Sanofi Pasteur INC. | $19.62 | 2019 | |
| Watermark Medical, INC. | $18.89 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.69 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.44 | 2025 | Breztri |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.32 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.98 | 2024 | Xifaxan |
| Eisai INC. | $15.48 | 2022 | |
| Paratek Pharmaceuticals, INC. | $12.79 | 2021 | |
| Eyevance Pharmaceuticals LLC | $12.66 | 2021 | |
| Hikma Pharmaceuticals USA | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dodd Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.